4Followers on Owler
Oncopeptides
Oncopeptides is a pharmaceutical company that develops and commercializes therapies for the treatment of hematological cancer.
Read more
Annual Revenue
$13.1M
Employees
88
Funding
$47.1M
Industry
Sector
Key Highlights
Looking for similar companies to Oncopeptides?
Oncopeptides Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$13.1M
Oncopeptides's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 10.2B. Over the last three quarters, Oncopeptides's revenue has grown by 179.1%. Specifically, in Q3 2021's revenue was $6.2M; in Q2 2021, it was $7.8M; in Q1 2021, it was $2.2M.
Oncopeptides News
Oncopeptides Press Releases
Oncopeptides Headquarters
Oncopeptides Summary
ABOUT
Overview
Oncopeptides is a pharmaceutical company that develops and commercializes therapies for the treatment of hematological cancer. Oncopeptides was founded in 2000. Oncopeptides' headquarters is located in Stockholm, Stockholms län, SE 111 37. Oncopeptide...Website
oncopeptides.seCompetitors
View 10 Oncopeptides competitors here.Acquisitions
There have been no acquisitions found related to OncopeptidesInvestments
Recent investment data cannot be found related to OncopeptidesFrequently Asked Questions about Oncopeptides
When was Oncopeptides founded?
Oncopeptides was founded in 2000Who is Oncopeptides's CEO?
Oncopeptides's CEO is Jakob LindbergHow much revenue does Oncopeptides generate?
Oncopeptides generates $13.1M in revenueHow much funding does Oncopeptides have?
Oncopeptides has historically raised $47.1M in funding
Where is Oncopeptides's headquarters?
Oncopeptides's headquarters is in Stockholm Stockholms län, SEHow many employees does Oncopeptides have?
Oncopeptides has 88 employeesWhat sector does Oncopeptides operate in?
Oncopeptides is in PharmaceuticalsWho are Oncopeptides's competitors?
Oncopeptides's top competitors are Cellectis, OncoImmune, Amphivena
Trending Companies
IN THE NEWS
Zogenix | Sanofi | MPS | Baltcom | Dexcom | CarbonChain | IMF | Quest Diagnostics | Pebblebrook Hotel | PayPal | Suzlon | Occidental | Midwest Retail Properties | Molson Coors | Mylan | Semtech | Ionis | AIM NA | Gnusbrands | Boston Scientific | Corning | T. Rowe Price | Linde | Airbnb | Union Pacific | EnLink | Brink's | Bloomingdale's | Eclipse | GoodRx | WM | Blink | CallidusCloud | TD Bank | Six Flags | ChampionX | Anaplan | Xaar | Synchronous Health | Emerson Electric | Spotlight Brands | Essex | Monster Beverage | Johnson & Johnson | Digital Realty | PNC | AbbVie | John Lewis | Fashionphile | Veeva
PEOPLE ALSO VIEWED
Axeb Biotech | BiomeSense | Nohla | Culture Biosciences, Inc. | Melanotan US Inc. | Lipomed | Scientific Search | Sapphire Bioscience | Mosquitomate | Tubulis | Takara Bio | Acerus | Maverick Therapeutics | A&A Phamachem | NeurogesX | V Beaute | Spyderco | infiniRel | AFLEX LTD | A+ Glass Tinting | Qihan Biotech | Briar Patch Biosciences | Molecular Infusions | Advansta Inc | DIARECT | Kalyani Group | Claim Pal | Konation Media | Point72 Ventures | Florista | Cellectis competitors | OncoImmune competitors | Amphivena competitors | CSL Behring competitors | Disc Medicine competitors | BMS competitors | Karyopharm competitors | AbbVie competitors | Autolus competitors | Spectrum competitors